UNSPSC 51342901: Didanosine

This classification denotes a reverse transcriptase inhibitor with the molecular formula C10H12N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K3GDH6OH08, chemically known as 2,3-dideoxyinosine & scd4(soluble recombinant protein) but generally known as didanosine, which bears US NIH Compound Identifier 50599. European Medicines Agency schedules Didanosine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07104MIG. The term DIDANOSINE is an International Non-Proprietary Name.

UNSPSC 51342901 Didanosine, a Commodity code, covers pharmaceutical products purchased by state and local health agencies, though the recent solicitations under this code tag show significant mismatch with the nominal scope. The code is tagged to purchases of antiretroviral medications and related pharmaceutical supplies, but the two most recent state and local opportunities posted against it involve unrelated drugs—doxycycline and ciprofloxacin (antibiotics) in one case and naloxone with drug deactivation systems in another. State health departments and county public health agencies are the primary issuing bodies pursuing pharmaceutical procurement through cooperative purchasing vehicles and competitive bidding. The Illinois Department of Public Health and Seminole County, Florida appear in the recent record, though the code's activity is sparse and geographically scattered, suggesting either narrow demand for didanosine specifically or broader miscategorization of pharmaceutical buys across the UNSPSC taxonomy.

The Illinois Department of Public Health awarded a completed contract on August 28, 2026 through the MMCAP Infuse consortium to Chartwell Rx LLC for pharmaceutical warehouse supply via Invitation for Bid, with a total award of $2,999,999.11 over a 12-month initial term plus two renewal options. Seminole County, Florida posted an IFB on June 30, 2026 (with a response deadline of July 26, 2023—an apparent date error in the source) for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford. Neither opportunity directly solicits didanosine. Business development professionals should verify whether this code accurately captures didanosine procurement activity or whether state and local agencies tag antiretroviral medications under different UNSPSC classifications; the mismatch between the code name and the recent posted work suggests limited or misaligned activity under the nominal scope.